ロード中...
Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study
The aims of this multicentric retrospective study were to assess in a real-world setting the effectiveness and safety of canagliflozin 100 mg/d (CANA100) as an add-on to the background antihyperglycemic therapy, and to evaluate the intensification of prior sodium–glucose co-transporter type 2 inhibi...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408903/ https://ncbi.nlm.nih.gov/pubmed/32708943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072275 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|